
-
2012
Company Description
DeuteRx provides research and development-focused biotechnology that improves racemic small molecule marketed drugs and drug candidates.
DeuteRx is a research and development-focused biotechnology company dedicated to improving racemic small molecule marketed drugs and drug candidates intended for patients across multiple therapeutic indications.
-
Manufacturer:
Science and Engineering -
Formed:
2012 -
Company Website:
-
Company E-mail:
-
Company Address:
300 Brickstone Square,, Suite 201Andover, MAUnited States -
CEO:
- Sheila DeWitt
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits